New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
COMPASS Pathways plc (Nasdaq:CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed a study published in the New England Journal of Medicine (NEJM) yesterday, which showed signals of positive activity in COMP360 psilocybin compared with the standard antidepressant escitalopram, for major depressive disorder (MDD). The […]
Tryp Therapeutics to Host Investor Day on April 22
San Diego, California–(Newsfile Corp. – April 15, 2021) – Tryp Therapeutics Inc. (CNSX:TRYP.CN) (OTCQB:TRYPF) (” Tryp ” or the ” Company “), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it will be hosting its quarterly Investor Day on Thursday, April 22 at 9:00 a.m. PDT. Tryp would like to invite […]
Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
Toronto, Ontario–(Newsfile Corp. – April 15, 2021) – Mindset Pharma Inc. (CNSX:MSET.CN) (FSE:9DF) (OTCQB:MSSTF) (” Mindset ” or the ” Company “) is pleased to announce that it has completed the previously announced “bought deal” public offering through the issuance of an aggregate of 10,000,000 units (each, a ” Unit “) of the Company at a price of $0.75 per Unit (the ” Issue […]
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CNSX:COOL.CN)(OTCPINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the “Company” or “Core One”) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth Opportunity Corporation) (PBIC) (“PBIC”) to rescind the share exchange transaction previously completed between the parties (the “Share Exchange”). Effective March 16, 2020, […]
